
New deals this week span across ophthalmology to Alzheimer’s, with three new acquisitions and one research collaboration.
Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.
Pharmaceutical Executive recently conducted an in-depth survey on the current landscape and potential outlook for the life sciences industry, drawing valuable feedback from top decision-makers in biopharma.






